Abstract

Comparative in vitro metabolic activity of human and rat liver fractions toward 5 ring-substituted methylcarbamates are reported. Human liver appeared to be less metabolically active than rat liver toward 4-dimethylamino-3,5-xylyl methylcarbamate (Zectran), 4-dimethylamino-3-cresyl methylcarbamate (Matacil), 4-methylthio-3,5-xylyl methylcarbamate (Mesurol), and 1-naphthyl methylcarbamate (carbaryl). In these studies the human liver metabolized 2-chloro-4,5-xylyl methylcarbamate (Banol) as well as did the rat. Both species produced esssentially the same major metabolites from the carbamates although quantitative differences were observed. Ring hydroxylation and N-dealkylation are the main oxidative metabolic pathways of carbamate metabolism studied in both the human and rat. The human liver produced a few metabolites not seen with the rat liver. The human liver had more difficulty oxidizing the N-methylcarbamate side chain to form the N-hydroxymethylcarbamate derivative of all the carbamates except Mesurol. In both species the major metabolic products from the carbamates retained the OC(O)NC group necessary for acetylcholinesterase inhibition.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call